Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice
Authors:
- Jenny L. WileyJWJenny L. Wiley
- Anthony F. CristelloACAnthony F. Cristello
- Robert L. BalsterRBRobert L. Balster
- 1 December 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 294 (1) , 101-107
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Antipunishment effects of acute and repeated administration of phencyclidine and NPC 12626 in ratsLife Sciences, 1992
- Possible involvement of nitric oxide in chlordiazepoxide-induced anxiolysis in miceLife Sciences, 1992
- Effects of HA‐966 on conflict, social interaction, and plus maze behaviorsDrug Development Research, 1991
- Use of a conflict procedure in pigeons to characterize anxiolytic drug activity: Evaluation of N-methyl-d-aspartate antagonistsLife Sciences, 1991
- The behavioral pharmacology of NMDA receptor antagonistsTrends in Pharmacological Sciences, 1990
- Noncompetitive excitatory amino acid receptor antagonistsTrends in Pharmacological Sciences, 1990
- Drug discrimination models in anxiety and depressionPharmacology & Therapeutics, 1990
- Anxiolytic properties of 1-aminocyclopropanecarboxylic acid, a ligand at strychnine-insensitive glycine receptorsPharmacology Biochemistry and Behavior, 1989
- Drug discrimination based on the competitive N-methyl-d-aspartate antagonist, NPC 12626Psychopharmacology, 1989
- Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the ratPharmacology Biochemistry and Behavior, 1986